Form 4: Angiodynamics CFO Reports Stock Transaction
Insider Transaction (Form 4)
Stephen A Trowbridge, EVP and CFO of Angiodynamics Inc, reported multiple transactions in common stock on July 22, 2026.
Summary
- Option exercise/conversion: acquired 16,296 Common Stock on July 22, 2026; holds 314,115 after (Direct).
- Tax/exercise-price withholding: disposed of 8,319 Common Stock at $13.82 ($114,969) on July 22, 2026; holds 305,796 after (Direct).
- Option exercise/conversion: disposed of 57,381 Performance Right on July 22, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stephen A Trowbridge — Officer (EVP and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | Common Stock | 16,296 | — | — | 314,115 |
| 2026-07-22 | Tax/exercise-price withholding | Common Stock | 8,319 | $14 | $115.0K | 305,796 |
| 2026-07-22 | Option exercise/conversion | Performance Right | 57,381 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (16,296 shares) |
| 2026-07-22 | Tax/exercise-price withholding (8,319 shares) |
| 2026-07-22 | Option exercise/conversion (57,381 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Stephen A Trowbridge
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.